MedTrace Logo

Treatment and Management of Women With Bleeding Disorders

NCT00111215 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2007-03-13

No results posted yet for this study

Summary

The purpose of the study is to determine whether oral contraceptives, desmopressin acetate, and/or tranexamic acid are effective in the treatment of women with menorrhagia who are diagnosed with a bleeding disorder.

Conditions

  • Menorrhagia
  • Blood Coagulation Disorders
  • Blood Platelet Disorders
  • Von Willebrand Disease
  • Hematologic Disease

Interventions

DRUG

Tranexamic Acid

DRUG

Desmopressin Acetate

Sponsors & Collaborators

Principal Investigators

  • Nicole F Dowling, PhD · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00111215 on ClinicalTrials.gov